clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Nucleic Acid
IDT, SOPHiA Genetics Broaden Partnership to Clinical-Grade Technologies
Research
Probiotic Drink Spiked with Genetic Elements Helps Thwart Antimicrobial Resistance
Research
Chromosome Alterations Contribute to Drug Resistance in ER+ Breast Cancer
Research
Personal Genome Diagnostics to Develop LBx to Inform Eisai Drug Discovery…
News & Features
Johns Hopkins Researchers Refine TMB Calculations of Immunotherapy Response
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Nucleic Acid
IDT, SOPHiA Genetics Broaden Partnership to Clinical-Grade Technologies
Research
Probiotic Drink Spiked with Genetic Elements Helps Thwart Antimicrobial Resistance
Research
Chromosome Alterations Contribute to Drug Resistance in ER+ Breast Cancer
Research
Personal Genome Diagnostics to Develop LBx to Inform Eisai Drug Discovery…
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Multimedia
All
Webinars
eBooks
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Multimedia
Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical…
Webinars
The Next Era in Pathway Proteomics: Turnkey Targeted Quantitation Workflows
Webinars
Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Molecular Biology
Molecular Biology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Molecular Biology
Teamsters Health and Welfare Fund of Philadelphia Taps Color for Genomic...
December 3, 2019
Molecular Biology
DiamiR Nabs Grant to Develop Alzheimer’s Disease Diagnostic
November 22, 2019
Molecular Biology
Treading with Caution: PGx Test Developers Pursue Dialogue as FDA Maintains...
November 7, 2019
Molecular Biology
Genetic Counseling 2.0
November 6, 2019
Molecular Biology
Elysium Health Launches At-Home Test to Measure Rate of Aging, Biological...
November 4, 2019
Molecular Biology
Guardant Launches 10K-Patient Colorectal Cancer ECLIPSE Trial
October 25, 2019
Molecular Biology
Broad Team Develop CRISPR-Cas13 Combination Diagnostic-Antiviral
October 11, 2019
Molecular Biology
Illumina and Qiagen Enter 15-Year Diagnostics Partnership
October 8, 2019
Molecular Biology
NIH Commits $38M to Rare Disease Research and Affiliated Data Center
October 8, 2019
Molecular Biology
CareDx Gets Medicare Draft Coverage Decision for Heart Transplant Rejection Test
August 23, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-324x160.jpeg "DiamiR Nabs Grant to Develop Alzheimer’s Disease Diagnostic")
![Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1291-324x160.jpeg "NIH Commits $38M to Rare Disease Research and Affiliated Data Center")
